AQR CAPITAL MANAGEMENT LLC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$180,551
+$30,427 QoQ
Shares Held
75,230
-21.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 148 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. LXRX ranks #207 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in LXRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180,551 | 75,230 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $150,124 | 96,234 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $166,518 | 144,800 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $408,955 | 302,931 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,332,097 | 1,402,210 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $539,680 | 1,173,225 | Shares | Other | 2025-05-15 | |
| 2023-09-30 | $32,218 | 29,558 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $64,250 | 28,057 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $89,796 | 47,014 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $720,525 | 300,219 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $99,644 | 47,677 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $469,939 | 119,274 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $978,156 | 203,359 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,491,768 | 325,004 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,404,027 | 239,187 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $415,198 | 121,403 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $926,140 | 643,153 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,410,066 | 1,205,033 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,814,700 | 1,443,436 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||